Unknown

Dataset Information

Approaches of targeting Rho GTPases in cancer drug discovery.


ABSTRACT:

Introduction

Rho GTPases are master regulators of actomyosin structure and dynamics and play pivotal roles in a variety of cellular processes including cell morphology, gene transcription, cell cycle progression, and cell adhesion. Because aberrant Rho GTPase signaling activities are widely associated with human cancer, key components of Rho GTPase signaling pathways have attracted increasing interest as potential therapeutic targets. Similar to Ras, Rho GTPases themselves were, until recently, deemed "undruggable" because of structure-function considerations. Several approaches to interfere with Rho GTPase signaling have been explored and show promise as new ways for tackling cancer cells.

Areas covered

This review focuses on the recent progress in targeting the signaling a

SUBMITTER: Lin Y 

PROVIDER: S-EPMC4824952 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature